BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,237,236 | +60.4% | 200,200 | +55.5% | 0.02% | 0.0% |
| Q4 2023 | $771,339 | -73.1% | 128,771 | -68.2% | 0.02% | -77.3% |
| Q3 2023 | $2,866,784 | +374.2% | 404,913 | +371.5% | 0.11% | +378.3% |
| Q2 2023 | $604,567 | -76.9% | 85,876 | -72.6% | 0.02% | -78.9% |
| Q1 2023 | $2,614,932 | +467.2% | 313,541 | +841.6% | 0.11% | +275.9% |
| Q4 2021 | $461,000 | +137.6% | 33,300 | +74.3% | 0.03% | +61.1% |
| Q1 2021 | $194,000 | -70.5% | 19,105 | -90.0% | 0.02% | -86.4% |
| Q3 2020 | $657,000 | – | 191,283 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |